Skip to main content
. 2015 Jan 21;6(8):5990–6000. doi: 10.18632/oncotarget.3337

Figure 2. The heterogeneity expression and phosphorylation status of survivin affects sensitivity to the survivin suppressant YM155 in HCC cells.

Figure 2

(A) The expression and phosphorylation status of survivin protein in a panel of HCC patients' tumor (T) and histologically matched normal (N) tissue samples by Western Blot analysis. (B) The expression and phosphorylation status of survivin protein in a panel of liver cancer cell lines and two normal liver tissues by western blotting analysis.